Table 2.
Authors [Ref.] | Tracer | Hybrid Imaging | Tomograph | Administered Activity | Uptake Time (min) |
Image Analysis |
---|---|---|---|---|---|---|
Sathekge et al. [20] | [68Ga]Ga-PSMA-11 | PET/CT | Not reported | Not reported | Not reported | Qualitative, Semiquantitative (SUVmean) |
Medina-Ornelas et al. [21] | [68Ga]Ga-PSMA-11 | PET/CT | Biograph mCT (Siemens) | Range: 88–240 MBq | 59 | Qualitative, Semiquantitative (SUVmax) |
Arslan et al. [22] | [68Ga]Ga-PSMA-11 | PET/CT | mCT 20 ultraHD LSO (Siemens) | Range: 77–350 MBq | 60 | Qualitative, Semiquantitative (SUVmax) |
Mushtaq et al. [23] | [68Ga]Ga-PSMA-11 | PET/CT | Discovery MV690 (GE) | Range: 107–958 MBq | 60 | Qualitative, Semiquantitative (SUVmax) |
Parghane et al. [24] | [68Ga]Ga-PSMA-11 | PET/CT | GEMINI TF (Philips) | Range: 74–111 MBq | 60 | Qualitative (PROMISE V2), Semiquantitative (SUVmax) |
Andryszak et al. [25] | [18F]PSMA-1007 | PET/CT | Discovery IT | 3MBq/kg | 60 | Qualitative, Semiquantitative (SUVmax, TBR) |
Legend: CT: computed tomography; PSMA: prostate-specific membrane antigen; MBq: MegaBecquerel; PET: positron emission tomography; PROMISE V2: prostate cancer molecular imaging standardised evaluation version 2; SUV: standardised uptake value; TBR: target-to-background ratio.